Our study is the first to confirm that propofol could inhibit the stemness and EMT of colon cancer cells at least partially through, SIRT1, and the Wnt and PI3K/AKT/mTOR signaling pathways. This evidence concerns the gene AKT1 and colonic neoplasm.